NOVARTIS INT PHARM LTD has a total of 166 patent applications. Its first patent ever was published in 1990. It filed its patents most often in EPO (European Patent Office), United States and Hong Kong. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are AVANIR PHARMACEUTICALS, BAYER SHERING PHARMA AG and NOVARTIS AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 25 | |
#2 | United States | 24 | |
#3 | Hong Kong | 16 | |
#4 | Colombia | 11 | |
#5 | China | 8 | |
#6 | Cyprus | 7 | |
#7 | Hungary | 6 | |
#8 | Argentina | 5 | |
#9 | Czechia | 5 | |
#10 | Israel | 5 | |
#11 | WIPO (World Intellectual Property Organization) | 5 | |
#12 | Austria | 4 | |
#13 | Malaysia | 4 | |
#14 | Norway | 4 | |
#15 | Slovakia | 4 | |
#16 | Bulgaria | 3 | |
#17 | Canada | 3 | |
#18 | Republic of Korea | 3 | |
#19 | Mexico | 3 | |
#20 | Poland | 3 | |
#21 | Australia | 2 | |
#22 | Brazil | 2 | |
#23 | Finland | 2 | |
#24 | Chile | 1 | |
#25 | Costa Rica | 1 | |
#26 | Germany | 1 | |
#27 | EAPO (Eurasian Patent Organization) | 1 | |
#28 | Luxembourg | 1 | |
#29 | Morocco | 1 | |
#30 | Netherlands | 1 | |
#31 | New Zealand | 1 | |
#32 | Peru | 1 | |
#33 | Singapore | 1 | |
#34 | Ukraine | 1 | |
#35 | Uruguay | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Machines | |
#5 | Environmental technology |
# | Name | Total Patents |
---|---|---|
#1 | Vere Hodge Richard Anthony | 18 |
#2 | Dunn Peter James | 10 |
#3 | Matthews John George | 10 |
#4 | Newbury Trevor Jack | 10 |
#5 | Greenway Michael John | 10 |
#6 | Huuskonen Anne | 9 |
#7 | Natunen Jari | 9 |
#8 | Quinn Paul | 9 |
#9 | Saloheimo Markku | 9 |
#10 | Kanerva Anne | 9 |
Publication | Filing date | Title |
---|---|---|
WO2013174927A1 | Production of fucosylated glycoproteins | |
WO2013102674A2 | Protease deficient filamentous fungal cells and methods of use thereof | |
WO2012069593A2 | Fusion enzymes having n-acetylglucosaminyltransferase activity | |
AU2006201058A1 | Use of secretin-receptor ligands in treatment of cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD) | |
IL141235D0 | Combined use of an alpha-adrenoceptor antagonist and a muscarinic antagonist in the manufacture of a medicament for the treatment of benign prostatic hyperplasia | |
US6683084B1 | Use of 2-amino purine derivatives for the treatment and prophylaxis of human herpes virus 6 infections | |
ATA122897A | METHOD FOR PRODUCING penciclovir and famciclovir | |
EP0850048A2 | Pharmaceutical granules | |
EP0822817A1 | Use of (r)-penciclovir triphosphate for the manufacture of a medicament for the treatment of viral diseases | |
US6469015B1 | Pharmaceutical formulation |